Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2000
12/13/2000EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/13/2000EP1059091A1 Transmucous sorbefacients
12/13/2000EP1059082A1 Use of substituted vinyltetrahydronaphthalenes and vinylbenzotetrahydropyrans as sunscreens
12/13/2000EP1058560A1 Topical ophthalmic preparations containing immunosuppressive agents
12/13/2000EP1058556A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
12/13/2000EP1058547A1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate
12/13/2000EP1058543A1 Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings
12/13/2000EP1058542A1 Method for producing encased spherical granular grains
12/13/2000EP1058540A1 Oral pellet with immediate release comprising glycerides subjected to polyglycolysis, method for making same
12/13/2000EP1058539A1 Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
12/13/2000EP1058538A1 Fast disintegrating tablets
12/13/2000EP0927196A4 Polymers containing polysaccharides such as alginates or modified alginates
12/13/2000EP0848608B1 Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
12/13/2000EP0702552B1 Solid fat nanoemulsions as drug delivery vehicles
12/13/2000CN1276732A Composition for controlling bacterial colonization
12/13/2000CN1276731A Insoluble insulin compositions
12/13/2000CN1276719A Rapidly disintegrating methylcellulose tablets
12/13/2000CN1276718A Rapidly disintegrating methylcellulose tablets
12/13/2000CN1276246A Process for preparing medicines with no or low loxic by-effect on gastrointestinal system
12/13/2000CN1276208A Formaldehyde injection for treating infective diseases of animal
12/13/2000CN1059447C Polypeptide toxins from spider
12/12/2000US6160165 Preparing a stirred slurry of pamidronate in water, adding a solution of sodium hydroxide to give a clear solution at ph of about 6.5, filtering, freezing and lyophilizing the solution to form amorphous anhydrous disodium pamidronate
12/12/2000US6160153 Phosphorothioate monoester functional crosslinking, conjugating and reducing agents
12/12/2000US6160084 Biodegradable shape memory polymers
12/12/2000US6160019 Dissolving 0.1 to 10% w/v of nimesulide in 2 to 90% w/v of dimethylacetamide to form a solution, adding benzyl alcohol, polyethylene glycol, hydrochloric acid, propylene glycol
12/12/2000US6160007 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
12/12/2000US6159977 Therapeutic anti-fungal nail preparation
12/12/2000US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases
12/12/2000US6159706 Application of enzyme prodrugs as anti-infective agents
12/12/2000US6159502 Oral delivery systems for microparticles
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159499 Composition containing an acid-labile benzimidazole and process for its preparation
12/12/2000US6159491 Prolonged release bioadhesive vaginal gel dosage form
12/12/2000US6159490 Pharmaceutical implant for the delivery of an effective amount of a bioactive peptide or peptide analog over a period of 1 to 12 months
12/12/2000US6159468 Activated protein C formulations
12/12/2000US6159458 Sustained release ophthalmic compositions containing water soluble medicaments
12/12/2000US6159447 In oral cavity; immobilized enzyme
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000CA2191754C Modification of clostridial toxins for use as transport proteins
12/11/2000CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/07/2000WO2000073471A1 Cationic lipids for gene transfer and preparation method thereof
12/07/2000WO2000073416A1 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
12/07/2000WO2000073374A1 Silicone gel containing salicylic acid
12/07/2000WO2000073353A1 Thermally-inhibited starch prepared with oligosaccharides
12/07/2000WO2000073346A1 Immunoconjugates having high binding affinity
12/07/2000WO2000073337A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073333A2 Ligand for cd7, and methods for use thereof
12/07/2000WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin
12/07/2000WO2000073271A1 Mutual salt of amlodipine and atorvastatin
12/07/2000WO2000072955A1 Method for producing morphologically uniform micro and nanoparticles using micromixers
12/07/2000WO2000072953A2 A method of producing organic emulsifiers and organic surfactants, products produced by said method, and the use of such products
12/07/2000WO2000072884A1 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
12/07/2000WO2000072883A2 Pharmaceutical transdermal compositions
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072874A1 IMMOBILIZED LACTOFERRIN (Im-LF) ANTIMICROBIAL AGENTS AND USES THEREOF
12/07/2000WO2000072873A1 Freeze dried hgf preparations
12/07/2000WO2000072872A1 Keratinocyte growth factor-2 formulations
12/07/2000WO2000072870A1 Compositions of a-beta peptide and processes for producing same
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072859A1 Balsam for the treatment of surface burns and chafing rashes
12/07/2000WO2000072851A1 Method of sterilizing
12/07/2000WO2000072848A1 Composition comprising (±)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1h,5h)-pyrimidinedione dissolved in 2,5-di-o-methyl-1,4:3,6-dianhydro-d-glucitol
12/07/2000WO2000072847A1 Ziprasidone suspension
12/07/2000WO2000072829A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072827A2 Porous drug matrices and methods of manufacture thereof
12/07/2000WO2000072825A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072822A1 Preparations for the application of anti-infective and/or anti-inflammatory agents
12/07/2000WO2000072821A1 Generation of therapeutic microfoam
12/07/2000WO2000072820A2 Injectable anesthetic formulation
12/07/2000WO2000072806A2 Sunscreen composition containing sol-gel microcapsules
12/07/2000WO2000072757A1 Surface stabilized microbubbles for use in ultrasound contrast and drug delivery agents
12/07/2000WO2000072701A1 Method and composition for masking mineral taste
12/07/2000WO2000072690A2 IMMOBILIZED LACTOFERRIN (Im-LF) ANTIMICROBIAL AGENTS AND USES THEREOF
12/07/2000WO2000050456A3 Covalently bridged insulin dimers
12/07/2000WO2000050035A3 Premixed formulation of piperacillin sodium and tazobactam sodium injection
12/07/2000WO2000050018A3 Pharmaceutical preparation containing dithranol
12/07/2000WO2000047166A3 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000045790A3 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
12/07/2000WO2000041681A3 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000WO2000032238A9 Stent having drug crystals thereon
12/07/2000DE19925613A1 Verbundlaminat und Verfahren zu seiner Herstellung A composite laminate and method of production
12/07/2000DE19925211A1 Kit for preparing stable paclitaxel formulation for use as anticancer agent, comprising separately stored drug, solution of anhydrous citric acid in ethanol and solution of polyethoxylated castor oil in ethanol
12/07/2000DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925143A1 Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie New liposomal vector complexes and their use for gene therapy
12/07/2000DE19925001A1 Stable liquid concentrate for preparing orally administered multiphase controlled drug release formulation, comprising water-miscible coherent phase and disperse phase releasing drug e.g. amoxicillin on dilution
12/07/2000CA2375829A1 Keratinocyte growth factor-2 formulations
12/07/2000CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000CA2375779A1 Lyophilized hgf preparation
12/07/2000CA2375700A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000CA2375237A1 Method of sterilizing
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2374946A1 Balsam for the treatment of surface burns and chafing rashes
12/07/2000CA2374897A1 Compositions of a-beta peptide and processes for producing same
12/07/2000CA2374288A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2374119A1 Method and composition for masking mineral taste
12/07/2000CA2374117A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2371247A1 Substantially oil-free cyclosporin compositions
1 ... 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 ... 1712